Future burden of myocardial infarction in Australia: impact on health outcomes between 2019 and 2038.

IF 4.8 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS European Heart Journal - Quality of Care and Clinical Outcomes Pub Date : 2024-08-08 DOI:10.1093/ehjqcco/qcad062
Tamrat Befekadu Abebe, Jedidiah I Morton, Jenni Ilomaki, Zanfina Ademi
{"title":"Future burden of myocardial infarction in Australia: impact on health outcomes between 2019 and 2038.","authors":"Tamrat Befekadu Abebe, Jedidiah I Morton, Jenni Ilomaki, Zanfina Ademi","doi":"10.1093/ehjqcco/qcad062","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Myocardial infarction (MI) remains a major health burden in Australia. Yet the future burden of MI has not been extensively studied for the Australian population.</p><p><strong>Methods and results: </strong>A multistate lifetable model was constructed to estimate the lifetime risk of MI and project the health burden of MI for the Australian population aged between 40 and 100 years over a 20-year period (2019-2038). Data for the model were primarily sourced from the Victorian-linked dataset and supplemented with other national data. The lifetime risk of MI at age 40 was estimated as 24.4% for males and 13.2% for females in 2018. From 2019 to 2038, 891 142 Australians were projected to develop incident MI. By 2038, the model estimated there would be 702 226 people with prevalent MI, 51 262 incident non-fatal MI, and 3717 incident fatal MI; these numbers represent a significant increase compared to the 2019 estimates, with a 27.0% (148 827), 62.0% (19 629), and 104.7% (1901) rise, respectively. Projected years of life lived (YLL) (5% discount) accrued by the Australian population was 174 795 232 (84 356 304 in males and 90 438 928 in females), with 7 657 423 YLL among people with MI (4 997 009 in males and 2 660 414 in females).</p><p><strong>Conclusion: </strong>The burden of MI was projected to increase between 2019 and 2038 in Australia. The outcomes of the model provide important information for decision-makers to prioritize population-wide prevention strategies to reduce the burden of MI.</p>","PeriodicalId":11869,"journal":{"name":"European Heart Journal - Quality of Care and Clinical Outcomes","volume":" ","pages":"421-430"},"PeriodicalIF":4.8000,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11307198/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal - Quality of Care and Clinical Outcomes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ehjqcco/qcad062","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Myocardial infarction (MI) remains a major health burden in Australia. Yet the future burden of MI has not been extensively studied for the Australian population.

Methods and results: A multistate lifetable model was constructed to estimate the lifetime risk of MI and project the health burden of MI for the Australian population aged between 40 and 100 years over a 20-year period (2019-2038). Data for the model were primarily sourced from the Victorian-linked dataset and supplemented with other national data. The lifetime risk of MI at age 40 was estimated as 24.4% for males and 13.2% for females in 2018. From 2019 to 2038, 891 142 Australians were projected to develop incident MI. By 2038, the model estimated there would be 702 226 people with prevalent MI, 51 262 incident non-fatal MI, and 3717 incident fatal MI; these numbers represent a significant increase compared to the 2019 estimates, with a 27.0% (148 827), 62.0% (19 629), and 104.7% (1901) rise, respectively. Projected years of life lived (YLL) (5% discount) accrued by the Australian population was 174 795 232 (84 356 304 in males and 90 438 928 in females), with 7 657 423 YLL among people with MI (4 997 009 in males and 2 660 414 in females).

Conclusion: The burden of MI was projected to increase between 2019 and 2038 in Australia. The outcomes of the model provide important information for decision-makers to prioritize population-wide prevention strategies to reduce the burden of MI.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
澳大利亚心肌梗死的未来负担:2019年至2038年对健康结果的影响。
背景:心肌梗死(MI)仍然是澳大利亚的主要健康负担。然而,尚未对澳大利亚人口的MI未来负担进行广泛研究。方法:构建一个多州生命表模型,以估计20年(2019-2028)内40至100岁的澳大利亚人群患心肌梗死的终身风险,并预测其健康负担。该模型的数据主要来源于与维多利亚州相关的数据集,并辅以其他国家数据。结果:2018年,男性和女性从40岁起发生MI的终生风险分别为24.4%和13.2%。从2019-2038年,预计891142名澳大利亚人将患上偶发性MI。到2038年,该模型估计将有702226人患有流行性MI,51262人发生非致命性MI,3177人发生致命性MI;与2019年的估计相比,这些数字有了显著的增长,分别增长了27.0%(148827)、62.0%(19629)和104.7%(1901)。澳大利亚人口的预期寿命(YLL)(5%折扣)为174 795 232(男性为84356 304,女性为90 438 928),其中MI患者的预期寿命为7 657 423(男性为4 997 009,女性为2 660 414)。结论:2019年至2038年间,澳大利亚MI负担预计将增加。该模型的结果为决策者提供了重要信息,以优先考虑全人群的预防策略,从而减轻MI的负担。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
9.40
自引率
3.80%
发文量
76
期刊介绍: European Heart Journal - Quality of Care & Clinical Outcomes is an English language, peer-reviewed journal dedicated to publishing cardiovascular outcomes research. It serves as an official journal of the European Society of Cardiology and maintains a close alliance with the European Heart Health Institute. The journal disseminates original research and topical reviews contributed by health scientists globally, with a focus on the quality of care and its impact on cardiovascular outcomes at the hospital, national, and international levels. It provides a platform for presenting the most outstanding cardiovascular outcomes research to influence cardiovascular public health policy on a global scale. Additionally, the journal aims to motivate young investigators and foster the growth of the outcomes research community.
期刊最新文献
Antithrombotic therapy following transcatheter aortic valve implantation: a Danish nationwide study. Intersectionality of inequalities in revascularisation and outcomes for acute coronary syndrome in England: nationwide linked cohort study. Assessing the Health Impact of Low Seafood Omega-3 Intake on Ischemic Heart Disease: Trends, Demographic Disparities, and Forecasts. Temporal trends of prescription rates, oral anticoagulants dose, clinical outcomes and factors associated with non-anticoagulation in patients with incident atrial fibrillation. Bariatric Surgery and Cardiovascular Outcomes in Patients with Obesity, Metabolic Dysfunction-Associated Steatotic Liver Disease, and Coronary Artery Disease: A Population-Based Matched Cohort Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1